F Casafont
Overview
Explore the profile of F Casafont including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
San Segundo D, Alonso C, Ruiz P, Romon I, Arias-Loste M, Cuadrado A, et al.
Transplant Proc
. 2016 Dec;
48(9):2980-2982.
PMID: 27932124
Introduction: Information about the consequences of de novo donor-specific anti-human leukocyte antigen (DSA) antibody development in the long term after adult liver transplantation (LT) is scarce. We conducted a cross-sectional...
2.
San Segundo D, Ruiz P, Irure J, Arias-Loste M, Cuadrado A, Puente A, et al.
Transplant Proc
. 2016 Dec;
48(9):2977-2979.
PMID: 27932123
Introduction: Accumulating evidence indicates that interleukin (IL)-34 participates in T-cell homeostasis and tolerance due to the ability of IL-34 to trigger apoptosis of Th1, Th17, and Tc1 cells, but spare...
3.
Garcia M, Jurado F, San Segundo D, Lopez-Hoyos M, Iruzubieta P, Llerena S, et al.
Transplant Proc
. 2015 Feb;
47(1):93-6.
PMID: 25645780
Introduction: The achievement of a state of tolerance and minimization of the immunosuppressive load form part of the "Holy Grail" in solid organ transplantation. Galectin-1 recently has been described to...
4.
Buti M, Tabernero D, Mas A, Homs M, Prieto M, Rodriguez-Frias F, et al.
Transpl Infect Dis
. 2015 Feb;
17(2):208-20.
PMID: 25641570
Aims: To investigate an optimal long-term prophylactic strategy for prevention of hepatitis B virus (HBV) recurrence after liver transplantation, we conducted a randomized study of 29 transplant recipients receiving a...
5.
Fabrega E, Lopez-Hoyos M, San Segundo D, Casafont F, Moraleja I, Sampedro B, et al.
Transplant Proc
. 2012 Jul;
44(6):1536-8.
PMID: 22841206
Introduction: Interleukin-9 (IL-9) has recently been described to be involved in the maintenance of a tolerant environment, but there is no evidence of its role in human liver transplantation. The...
6.
Fabrega E, Lopez-Hoyos M, San Segundo D, Casafont F, Angel Mieses M, Sampedro B, et al.
Transplant Proc
. 2012 Jul;
44(6):1533-5.
PMID: 22841205
Introduction: Interleukin-9 (IL-9) has been cast as a player in autoimmunity, but its role in liver transplantation remains to be clarified. The aim of our study was to investigate the...
7.
Sampedro B, Cabezas J, Fabrega E, Casafont F, Pons-Romero F
Transplant Proc
. 2011 Apr;
43(3):679-82.
PMID: 21486572
Introduction: Orthotopic liver transplantation has shown successful results over the last years. For this reason there are increased numbers of patients on waiting lists. To expand the pool of liver...
8.
Herrera L, Martino E, Rodriguez-Sanjuan J, Castillo J, Casafont F, Gonzalez F, et al.
Transplant Proc
. 2009 Apr;
41(3):1054-6.
PMID: 19376425
Traumatic neuromas (TN) of the biliary tree causing strictures have only occasionally been described after liver transplantation. Herein, we have reported 15 cases of TN that were detected between 1...
9.
Fabrega E, Lopez-Hoyos M, San Segundo D, Casafont F, Benito M, Pons-Romero F
Transplant Proc
. 2009 Apr;
41(3):1025-7.
PMID: 19376417
Introduction: T(H)17 cells have been recently described to be involved in inflammatory and immune-mediated diseases, but there is no evidence of their role in human liver transplantation. Interleukin (IL)-23 is...
10.
Fabrega E, Unzueta M, Cobo M, Casafont F, Amado J, Romero F
Transplant Proc
. 2007 Sep;
39(7):2295-6.
PMID: 17889168
Introduction: CD30 is a membrane glycoprotein that belongs to the tumor necrosis factor superfamily. It is expressed on activated T cells. After activation of CD30(+) T cells, a soluble form...